Daisy Cai

Daisy Cai is a seasoned marketing professional with extensive experience in the pharmaceutical sector. Currently serving as Marketing Director at AstraZeneca since August 2023, Daisy Cai has demonstrated exceptional leadership in the hepatobiliary cancer area, notably by launching a PD-L1 immunoncology drug and outpacing a key competitor within a short timeframe. Prior to this role, Daisy Cai held senior marketing positions at Innovent Biologics and Qilu Pharmaceuticals, and served as Investment Vice President of Healthcare at Hiforturn. Daisy Cai's early career includes significant contributions at Roche and a foundational role at AstraZeneca, engaging in scientific communication and organizing forums on advanced treatment strategies. Daisy Cai holds a Bachelor’s degree in Medicine from Fudan University.